Metropolis Healthcare Limited (METROPOLIS) announces strategic plans from Investor & Analyst Meet 2026 to strengthen core, expand adjacencies, and compound s.
Metropolis Healthcare Limited (METROPOLIS) reports strong Q1FY27 performance with revenue up 17% to ₹450 crore and EBITDA up 27% YoY.
Metropolis Healthcare Limited (NSE: METROPOLIS) stock moves up 5% intraday to ₹574.15, successfully clearing resistance at ₹550.
Metropolis Healthcare Limited (NSE: METROPOLIS) stock falls 6% intraday to ₹541.65, showing pressure after a breakout.
Metropolis Healthcare Limited (NSE: METROPOLIS) gains 5% intraday to ₹554.5, showing a recovery despite an underlying trendline breakdown.
Metropolis Healthcare Limited (NSE: METROPOLIS) gains 5% intraday to ₹554.5, showing a recovery despite an underlying trendline breakdown..
Metropolis Healthcare Limited (METROPOLIS) reports strong Q4 & FY26 results with revenue up 32% and PAT surging 23%.